Table 1.
Pre-surgery clinical data for diabetic and control cataract subjects
| Group* | No. | Eye | Age | F/M | VA pre | VA post | HbA1c (%) | GA (%) |
|---|---|---|---|---|---|---|---|---|
| Mild | 15 | 22 | 67.7 ± 8.2 | 9/6 | 0.56±0.28 | 0.06±0.04 | 7.65 ± 1.75 | 17.18 ± 2.43 |
| Moderate | 20 | 31 | 65.9 ± 7.5 | 11/9 | 0.75±0.35 | 0.27±0.06 | 7.61 ± 1.48 | 17.58 ± 2.11 |
| Severe | 14 | 21 | 68.4 ± 7.8 | 7/5 | 1.43±0.42 | 1.12±0.48 | 7.88 ± 1.52 | 17.93 ± 2.85 |
| Control | 13 | 21 | 66.5 ± 6.9 | 7/6 | 0.62±0.19 | 0.05±0.04 | 4.92 ± 0.77 | 15.57 ± 2.02 |
No., patient number in each group; Eye, eye number in each group; VA pre, average logMAR BCVA before cataract surgery; VA post, average logMAR BCVA after cataract surgery; F/M, female/male number of patients; HbA1c, glycosylated hemoglobin, which reflects the blood sugar change in the last 8–12 weeks prior to surgery; GA, glycated albumin, which reflects the blood sugar change in the last four weeks prior to surgery
*The grouping is based on the BCVA 1 month after cataract surgery: mild (LogMAR visual acuity, ≤ 0.1), moderate (0.1 < logMAR < 0.5), and severe (LogMAR visual acuity, ≥ 0.5)